Edit
AbFero Pharmaceuticals, Inc.
https://www.abferopharmaceuticals.com/Last activity: 17.02.2021
Active
Our mission is to develop best-in-class, safe and effective oral iron chelators for the treatment of diseases of iron overload.
Location: United States, Massachusetts, Lexington
Employees: 11-50
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Deepwork C... | deepworkca... |
| - | K2X | k2x.capita... |
Mentions in press and media 2
| Date | Title | Description |
| 17.02.2021 | AbFero Pharmaceuticals Announces Funding From Cure Parkinson's For Lead Compound SP-420 | |
| 09.12.2020 | AbFero Pharmaceuticals Pushes Toward Phase 1-2 Trial | Following the completion of a 12-patient normal volunteer PK trial, AbFero Pharmaceuticals CEO Thomas Neenan has announced that “AbFero’s lead iron chelator [is] one step closer to the patients who need it most.” Results of the study reveal... |